Autopsy report · NCT01170364

Studying the Effects of Sibutramine on Eating Behavior

“Terminated due to sibutramine being withdrawn from the market.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 2 months after it had already started.
• Ran for about 1 year 8 months before it stopped.
• 14 participants enrolled.
• Results were posted on the registry 6 years 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

New York State Psychiatric Institute

Sponsor type

University, hospital or other

Conditions

Obesity

Interventions

Sibutramine; Placebo

Participants

14

Sites

1

Countries

United States

Trials that died the same way

• Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice
  “Terminated after FDA agreement.” (65% match in meaning)
• Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer
  “Terminated due to unacceptable toxicity” (65% match in meaning)
• Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma
  “Terminated 4/17/07. Drug sponsor withdrew.” (64% match in meaning)
• Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors
  “Terminated due to low accrual.” (64% match in meaning)
• Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer
  “Terminated due to lack of efficacy” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.